Secondary Myelodysplastic Syndrome in a Patient with Philadelphia-Positive Acute Lymphoblastic Leukemia after Achieving a Major Molecular Response with HyperCVAD plus Imatinib Mesylate

The addition of imatinib to high-intensity chemotherapy has improved the outcome of patients with Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL). However, the possible long-term side effects of this combination are not yet known. Development of new clonal abnormalities in c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vega-Ruiz, Arturo, O’Brien, Susan, Cortes, Jorge, Kebriaei, Partow, Thomas, Deborah, Kantarjian, Hagop, Ravandi, Farhad
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086363/
https://ncbi.nlm.nih.gov/pubmed/18355919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2008.02.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados